Ferroptosis regulation of GLS2 as a potential therapeutic strategy against liver diseases

A new editorial paper was published in Oncotarget’s Volume 14 on October 19, 2023, entitled, “GLS2 shapes ferroptosis in hepatocellular carcinoma.”

ASU professor offers insights on what may be coming from Neuralink’s PRIME study

This week, Neuralink’s Elon Musk announced that human clinical trials have begun on its Precise Robotically Implanted Brain-Computer Interface (PRIME) study, a medical device trail

February 3, 2024

The UAE Is Exploring the Rollout of Psychedelic Assisted Therapies | Psychedelic Invest

The Energia Foundation and Tabula Rasa Ventures, notable for introducing psychedelic education at Davos in 2022, have been at the forefront of bringing understanding of psychedelic-assisted therapy to the Arabian

March 7, 2024

Bivalent COVID Shots May Hold Up Better Against Severe Omicron

A second booster with an mRNA bivalent vaccine offered the best protection against severe COVID-19 due to the Omicron BA.5 variant in older adults, and

July 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.